BUSINESS
Top selling drugs face patent expiration between 2018 and 2024, sales worth $251 bn at stake: Report
BUSINESS
Sun Pharma’s Halol EIR, no respite in Fortis saga were key highlights of this week
BUSINESS
US court restrains Dr Reddy's from selling generic de-addiction drug Suboxone
BUSINESS
How Sun Pharma managed to get its Halol facility off the USFDA hook
BUSINESS
Dr Reddy's gets USFDA nod to launch generic Suboxone, opts for 'at risk' launch
BUSINESS
DCGI asks retailers to have separate racks to sell generic drugs, trade groups are not amused
BUSINESS
Fortis calls off demerger of diagnostics arm, SRL, citing headwinds for the sector
BUSINESS
Sun Pharma gets EIR for crucial Halol plant, US sales to get boost
BUSINESS
Statutory auditor holds signing of Fortis Q4 accounts for want of more information
BUSINESS
Fortis defers Q4 results by 2 weeks, says it needs time to consider internal investigation report
BUSINESS
Pharma wrap: NHPS package rates spook private healthcare providers
BUSINESS
Govt to not push compulsory use of generic drugs in NHPS, say sources
BUSINESS
How Natco defied the odds to rise up India's pharma ladder
BUSINESS
Pharma weekly wrap: Fortis re-opens bid process, Delhi govt proposes price caps; cos report Q4 earnings
BUSINESS
Delhi govt proposals to rein-in pvt hospitals may hit legal road blocks
BUSINESS
Fortis board shortlists four bidders to participate in the sale process
BUSINESS
Lupin launches specialty women health drug Solosec in US
BUSINESS
Fortis postpones Q4 earnings citing deliberations over outcome of internal investigation
BUSINESS
Indian drug cos scramble to comply with new data regulation in EU, the second largest market for exports
BUSINESS
L&T says private sector capex is still muted, revival could take two years
BUSINESS
Pharma Weekly Wrap: Never-ending Fortis saga, Q4 numbers hog limelight
BUSINESS
Indian pharma market grows 7.8 percent in December on uptake in respiratory and anti-infectives
BUSINESS
Pharma wrap: Pharma stocks gain on BJP retaining Gujarat, medical device makers open to regulation
BUSINESS
We support govt's move to regulate trade margins: MNC devices lobby
